SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 189.55+3.5%Dec 12 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Option Player who wrote (4127)7/16/1997 4:59:00 PM
From: Sunny Jim   of 32384
 
Option,

I wouldn't say that the stock sucks any more than the rest of the biotech sector today. I own four biotechs and all were down except BTGC, which oddly enough is the only one with drug sales and profitability (extremely rare in biotech). I did talk to LGND investor relations today and frankly, if I had to make any decision based on the information I got, I would sell the stock. The word on the leptin deal is, "it is still in progress". I'll just toss this out as an idea - the deal is all but dead, and when they have some other news to offset it, they will announce it. I wish that my conversation had given me more confidence, but it didn't. If anyone else talks to IR and gets any useful information, please post it.

Jim ,
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext